HA
HC Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,479
| Closed | -$224K | – | 52 |
|
|
2024
Q1 | $224K | Buy |
+1,479
| New | +$224K | 0.11% | 83 |
|
|
2023
Q1 | – | Sell |
-2,075
| Closed | -$253K | – | 82 |
|
|
2022
Q4 | $253K | Sell |
2,075
-500
| -19% | -$61.1K | 0.17% | 66 |
|
|
2022
Q3 | $266K | Sell |
2,575
-71
| -3% | -$7.33K | 0.18% | 66 |
|
|
2022
Q2 | $246K | Buy |
2,646
+2
| +0.1% | +$186 | 0.18% | 64 |
|
|
2022
Q1 | $310K | Sell |
2,644
-292
| -10% | -$34.2K | 0.2% | 62 |
|
|
2021
Q4 | $395K | Buy |
2,936
+565
| +24% | +$76K | 0.24% | 52 |
|
|
2021
Q3 | $378K | Sell |
2,371
-84
| -3% | -$13.4K | 0.25% | 51 |
|
|
2021
Q2 | $323K | Sell |
2,455
-92
| -4% | -$12.1K | 0.2% | 57 |
|
|
2021
Q1 | $328K | Buy |
2,547
+50
| +2% | +$6.44K | 0.21% | 54 |
|
|
2020
Q4 | $416K | Buy |
2,497
+192
| +8% | +$32K | 0.28% | 50 |
|
|
2020
Q3 | $356K | Buy |
2,305
+258
| +13% | +$39.8K | 0.29% | 46 |
|
|
2020
Q2 | $303K | Buy |
+2,047
| New | +$303K | 0.25% | 62 |
|